Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
KEGG | hsa05225 | Hepatocellular carcinoma | 45/1364 | 168/8135 | 0.0006346 | 0.003611 | 0.002336 | 45 | RABC85 | |
KEGG | hsa04625 | C-type lectin receptor signaling pathway | 31/1364 | 104/8135 | 0.0006418 | 0.003611 | 0.002336 | 31 | RABC85 | |
KEGG | hsa04917 | Prolactin signaling pathway | 23/1364 | 70/8135 | 0.0007147 | 0.003954 | 0.002558 | 23 | RABC85 | |
KEGG | hsa05202 | Transcriptional misregulation in cancer | 50/1364 | 193/8135 | 0.0007502 | 0.004083 | 0.002641 | 50 | RABC85 | |
KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 99/1836 | 222/8135 | 0.000000000000139 | 0.0000000000465 | 0.0000000000317 | 99 | RABC11 | |
KEGG | hsa05169 | Epstein-Barr virus infection | 90/1836 | 202/8135 | 0.00000000000197 | 0.000000000329 | 0.000000000224 | 90 | RABC11 | |
KEGG | hsa05164 | Influenza A | 72/1836 | 171/8135 | 0.0000000068 | 0.000000758 | 0.000000516 | 72 | RABC11 | |
KEGG | hsa04380 | Osteoclast differentiation | 57/1836 | 128/8135 | 0.0000000239 | 0.00000199 | 0.00000136 | 57 | RABC11 | |
KEGG | hsa05170 | Human immunodeficiency virus 1 infection | 81/1836 | 212/8135 | 0.000000144 | 0.00000965 | 0.00000657 | 81 | RABC11 | |
KEGG | hsa05162 | Measles | 57/1836 | 139/8135 | 0.000000729 | 0.0000349 | 0.0000237 | 57 | RABC11 | |
KEGG | hsa04658 | Th1 and Th2 cell differentiation | 42/1836 | 92/8135 | 0.000000731 | 0.0000349 | 0.0000237 | 42 | RABC11 | |
KEGG | hsa04659 | Th17 cell differentiation | 47/1836 | 108/8135 | 0.000000912 | 0.0000381 | 0.0000259 | 47 | RABC11 | |
KEGG | hsa04064 | NF-kappa B signaling pathway | 45/1836 | 104/8135 | 0.00000188 | 0.0000697 | 0.0000475 | 45 | RABC11 | |
KEGG | hsa05140 | Leishmaniasis | 36/1836 | 77/8135 | 0.00000225 | 0.000075 | 0.0000511 | 36 | RABC11 | |
KEGG | hsa04010 | MAPK signaling pathway | 100/1836 | 294/8135 | 0.00000329 | 0.0000999 | 0.000068 | 100 | RABC11 | |
KEGG | hsa04110 | Cell cycle | 51/1836 | 126/8135 | 0.00000436 | 0.0001213 | 0.0000826 | 51 | RABC11 | |
KEGG | hsa04640 | Hematopoietic cell lineage | 42/1836 | 99/8135 | 0.00000753 | 0.0001935 | 0.0001318 | 42 | RABC11 | |
KEGG | hsa04218 | Cellular senescence | 59/1836 | 156/8135 | 0.0000102 | 0.0002443 | 0.0001663 | 59 | RABC11 | |
KEGG | hsa05330 | Allograft rejection | 21/1836 | 38/8135 | 0.000012 | 0.0002672 | 0.0001819 | 21 | RABC11 | |
KEGG | hsa04660 | T cell receptor signaling pathway | 43/1836 | 104/8135 | 0.0000129 | 0.0002692 | 0.0001832 | 43 | RABC11 | |
KEGG | hsa05161 | Hepatitis B | 60/1836 | 162/8135 | 0.0000183 | 0.0003591 | 0.0002445 | 60 | RABC11 | |
KEGG | hsa04662 | B cell receptor signaling pathway | 35/1836 | 82/8135 | 0.0000365 | 0.0006555 | 0.0004462 | 35 | RABC11 | |
KEGG | hsa05203 | Viral carcinogenesis | 71/1836 | 204/8135 | 0.0000373 | 0.0006555 | 0.0004462 | 71 | RABC11 | |
KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 68/1836 | 194/8135 | 0.0000419 | 0.0007 | 0.0004765 | 68 | RABC11 | |
KEGG | hsa03440 | Homologous recombination | 21/1836 | 41/8135 | 0.0000551 | 0.000862 | 0.0005868 | 21 | RABC11 | |
KEGG | hsa05165 | Human papillomavirus infection | 105/1836 | 331/8135 | 0.0000568 | 0.000862 | 0.0005868 | 105 | RABC11 | |
KEGG | hsa04630 | JAK-STAT signaling pathway | 58/1836 | 162/8135 | 0.000077 | 0.001089 | 0.0007413 | 58 | RABC11 | |
KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 49/1836 | 131/8135 | 0.0000783 | 0.001089 | 0.0007413 | 49 | RABC11 | |
KEGG | hsa04210 | Apoptosis | 50/1836 | 136/8135 | 0.0001104 | 0.001467 | 0.0009988 | 50 | RABC11 | |
KEGG | hsa05160 | Hepatitis C | 56/1836 | 157/8135 | 0.0001142 | 0.001467 | 0.0009988 | 56 | RABC11 |